Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antigen-specific vaccines for cancer treatment
Maria Tagliamonte, Annacarmen Petrizzo, Maria Lina Tornesello, et al.
Human Vaccines & Immunotherapeutics (2014) Vol. 10, Iss. 11, pp. 3332-3346
Open Access | Times Cited: 145

Showing 1-25 of 145 citing articles:

Emerging Concepts and Technologies in Vaccine Development
Morgan Brisse, Sophia M. Vrba, Natalie M. Kirk, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 258
Metallic nanoparticles for cancer immunotherapy
Emily Evans, Pallavi Bugga, Vishwaratn Asthana, et al.
Materials Today (2017) Vol. 21, Iss. 6, pp. 673-685
Open Access | Times Cited: 205
Vaccine Therapies for Cancer: Then and Now
Michael A. Morse, William R. Gwin, Duane A. Mitchell
Targeted Oncology (2021) Vol. 16, Iss. 2, pp. 121-152
Open Access | Times Cited: 171
Comparison of DNA and mRNA vaccines against cancer
Zohreh Jahanafrooz, Behzad Baradaran, Jafar Mosafer, et al.
Drug Discovery Today (2019) Vol. 25, Iss. 3, pp. 552-560
Open Access | Times Cited: 156
Exosome-Based Vaccines: History, Current State, and Clinical Trials
Patrick Santos, Fausto Almeida
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 156
Prophylactic and Therapeutic HPV Vaccines: Current Scenario and Perspectives
Yicheng Mo, Jiabing Ma, Hongtao Zhang, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 95
Emerging strategies in targeting tumor-resident myeloid cells for cancer immunotherapy
Yi Wang, Kai Conrad Cecil Johnson, Margaret E. Gatti‐Mays, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 93
Peptide-based vaccine for cancer therapies
Luigi Buonaguro, Maria Tagliamonte
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 43
Revolutionizing cancer care strategies: immunotherapy, gene therapy, and molecular targeted therapy
Aasma Zafar, Muhammad Jawad Khan, J Abu, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Open Access | Times Cited: 17
Roles of human papillomavirus in cancers: oncogenic mechanisms and clinical use
Yu Zhang, Ke Qiu, Jianjun Ren, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 3
Virus-Based Nanoparticles as Versatile Nanomachines
Kristopher J. Koudelka, Andrzej S. Pitek, Marianne Manchester, et al.
Annual Review of Virology (2015) Vol. 2, Iss. 1, pp. 379-401
Open Access | Times Cited: 155
Advancements in prophylactic and therapeutic nanovaccines
Prateek Bhardwaj, Eshant Bhatia, Shivam Sharma, et al.
Acta Biomaterialia (2020) Vol. 108, pp. 1-21
Open Access | Times Cited: 127
Targeted drug delivery to melanoma
Qi Liu, Manisit Das, Yun Liu, et al.
Advanced Drug Delivery Reviews (2017) Vol. 127, pp. 208-221
Closed Access | Times Cited: 124
A concise review on cancer treatment methods and delivery systems
Elham Bidram, Yasaman Esmaeili, Hadi Ranji‐Burachaloo, et al.
Journal of Drug Delivery Science and Technology (2019) Vol. 54, pp. 101350-101350
Closed Access | Times Cited: 108
Selecting Target Antigens for Cancer Vaccine Development
Luigi Buonaguro, Maria Tagliamonte
Vaccines (2020) Vol. 8, Iss. 4, pp. 615-615
Open Access | Times Cited: 104
Nanoparticle cancer vaccines: Design considerations and recent advances
Jingjing Liu, Lei Miao, Jiying Sui, et al.
Asian Journal of Pharmaceutical Sciences (2019) Vol. 15, Iss. 5, pp. 576-590
Open Access | Times Cited: 89
Colorectal Cancer Immune Infiltrates: Significance in Patient Prognosis and Immunotherapeutic Efficacy
Liang Guo, Chuanlei Wang, Xiang Qiu, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 87
Current Progresses and Challenges of Immunotherapy in Triple-Negative Breast Cancer
Karan Mediratta, Sara El‐Sahli, Vanessa M. D’Costa, et al.
Cancers (2020) Vol. 12, Iss. 12, pp. 3529-3529
Open Access | Times Cited: 87
Immune precision medicine for cancer: a novel insight based on the efficiency of immune effector cells
Jean‐François Rossi, Patrice Céballos, Zhao‐Yang Lu
Cancer Communications (2019) Vol. 39, Iss. 1, pp. 1-16
Open Access | Times Cited: 83
Recent progress of dendritic cell-derived exosomes (Dex) as an anti-cancer nanovaccine
Jingyi Xia, Yang‐Bao Miao, Xi Wang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 152, pp. 113250-113250
Open Access | Times Cited: 49
Immunotherapy for Colorectal Cancer: Mechanisms and Predictive Biomarkers
Lindsey Carlsen, Kelsey E. Huntington, Wafik S. El‐Deiry
Cancers (2022) Vol. 14, Iss. 4, pp. 1028-1028
Open Access | Times Cited: 41
Vaccine development: Current trends and technologies
Renu Poria, Deepak Kala, Rupak Nagraik, et al.
Life Sciences (2023) Vol. 336, pp. 122331-122331
Closed Access | Times Cited: 28
Poly-γ-glutamic acid nanoparticles as adjuvant and antigen carrier system for cancer vaccination
Vahideh Mohammadzadeh, Niloufar Rahiman, Horacio Cabral, et al.
Journal of Controlled Release (2023) Vol. 362, pp. 278-296
Closed Access | Times Cited: 26
Potential role of p53 deregulation in modulating immune responses in human malignancies: A paradigm to develop immunotherapy
Shivi Chauhan, Shivani Jaiswal, Vibhuti Jakhmola, et al.
Cancer Letters (2024) Vol. 588, pp. 216766-216766
Open Access | Times Cited: 12
The role of TLRs in cervical cancer with HPV infection: a review
Xiao Yang, Yanxiang Cheng, Chunsheng Li
Signal Transduction and Targeted Therapy (2017) Vol. 2, Iss. 1
Open Access | Times Cited: 86
Page 1 - Next Page

Scroll to top